IGM Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.81 | -$0.81 | -$0.81 |
| Q2 2024 | 4 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2024 | 8 | -$0.86 | -$0.75 | -$0.80 |
| Q4 2024 | 4 | -$0.72 | -$0.72 | -$0.72 |
| Q1 2025 | 4 | -$0.59 | -$0.59 | -$0.59 |
| Q2 2025 | 5 | -$0.54 | -$0.54 | -$0.54 |
| Q3 2025 | 4 | -$0.56 | -$0.56 | -$0.56 |
| Q4 2025 | 5 | -$0.58 | -$0.58 | -$0.58 |
| Q1 2026 | 3 | -$0.30 | -$0.30 | -$0.30 |
| Q2 2026 | 4 | -$0.29 | -$0.29 | -$0.29 |
| Q3 2026 | 3 | -$0.32 | -$0.32 | -$0.32 |
| Q4 2026 | 4 | -$0.34 | -$0.34 | -$0.34 |
| Q1 2027 | 3 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2027 | 4 | -$0.39 | -$0.39 | -$0.39 |
| Q3 2027 | 3 | -$0.40 | -$0.40 | -$0.40 |
| Q4 2027 | 4 | -$0.42 | -$0.42 | -$0.42 |
IGM Biosciences, Inc. Earnings Date And Information
IGM Biosciences, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.79 earnings per share for the quarter, missing analysts' consensus estimates of $-0.03778 by $0.75222. The company had revenue of 1.25 M for the quarter and had revenue of 2.13 M for the year. IGM Biosciences, Inc. has generated $-5 earnings per share over the last year ($-4.71 diluted earnings per share) and currently has a price-to-earnings ratio of -4.34. IGM Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
IGM Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$0.04 | -$0.79 | -0.75 | $54.31 M | $1.25 M |
| 05/08/2024 | Q1 2024 | -$0.84 | -$0.83 | 0.01 | $497,000 | |
| 03/07/2024 | Q4 2023 | -$1.06 | -$1.01 | 0.05 | $651,000 | |
| 11/13/2023 | Q3 2023 | -$1.25 | -$1.04 | 0.21 | $838,333 | $509,000 |
| 08/03/2023 | Q2 2023 | -$1.43 | -$1.43 | 0 | $797,000 | $448,000 |
| 05/12/2023 | Q1 2023 | -$1.37 | -$1.33 | 0.04 | $522,000 | |
| 03/30/2023 | Q4 2022 | -$1.53 | -$1.09 | 0.44 | $372,000 | |
| 11/03/2022 | Q3 2022 | -$1.45 | -$1.26 | 0.19 | $261,000 | $331,000 |
| 08/08/2022 | Q2 2022 | -$1.44 | -$1.32 | 0.12 | $51.88 M | $366,000 |
| 05/09/2022 | Q1 2022 | -$1.65 | -$1.53 | 0.12 | $0 | |
| 03/29/2022 | Q4 2021 | -$1.58 | -$1.50 | 0.08 | $0 | |
| 11/04/2021 | Q3 2021 | -$1.34 | -$1.32 | 0.02 | $0 | |
| 08/09/2021 | Q2 2021 | -$1.21 | -$1.16 | 0.05 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.98 | -$0.95 | 0.03 | $0 | |
| 03/30/2021 | Q4 2020 | -$0.74 | -$0.79 | -0.05 | $0 | |
| 11/05/2020 | Q3 2020 | -$0.67 | -$0.66 | 0.01 | $0 | |
| 08/06/2020 | Q2 2020 | -$0.61 | -$0.62 | -0.01 | $0 | |
| 05/07/2020 | Q1 2020 | -$0.52 | -$0.58 | -0.06 | $0 | |
| 03/26/2020 | Q4 2019 | -$0.36 | -$0.49 | -0.13 | $0 | |
| 11/07/2019 | Q3 2019 | -$0.82 | -$2.41 | -1.59 | $0 |
IGM Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is IGM Biosciences, Inc.'s earnings date?
IGM Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to IGM Biosciences, Inc.'s earnings conference call?
The conference call for IGM Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read IGM Biosciences, Inc.'s conference call transcript?
The conference call transcript for IGM Biosciences, Inc.'s latest earnings report can be read online.
-
How much revenue does IGM Biosciences, Inc. generate each year?
IGM Biosciences, Inc. (:IGMS) has a recorded annual revenue of $2.13 M.
-
How much profit does IGM Biosciences, Inc. generate each year?
IGM Biosciences, Inc. (:IGMS) has a recorded net income of $2.13 M. IGM Biosciences, Inc. has generated $-4.71 earnings per share over the last four quarters.
-
What is IGM Biosciences, Inc.'s price-to-earnings ratio?
IGM Biosciences, Inc. (:IGMS) has a price-to-earnings ratio of -4.34 and price/earnings-to-growth ratio is -0.29.
